Literature DB >> 21302100

Expression of ia antigens by murine keratinizing epithelial langerhans cells.

G Rowden1, T M Phillips, T L Delovitch.   

Abstract

Immunofluorescent and immunoelectron-microscopic staining methods were utilized to investigate the localization of Ia antigens in murine keratinizing epithelia. Approximately 3-5% of epidermal cells were shown to be Ia positive. Only dendritic Langerhans cells in the interfollicular epidermis and outer root sheaths were found to express Ia antigens. These Ia determinants were shown to be controlled by both theI- A andI- EC subregions of theH-2 complex. The results were confirmed by identifying positively stained cells containing Langerhans cell granules at the ultrastructural level. No staining was noted on the surface of keratinocytes, melanocytes, or immigrant lymphocytes. The results presented are in close agreement with those previously reported for Ia-bearing Langerhans cells in human and guinea pig epidermis.

Entities:  

Year:  1978        PMID: 21302100     DOI: 10.1007/BF01844036

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  34 in total

1.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.

Authors:  H F CLARK; C C SHEPARD
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  Langerhans cells: involvement in the pathogenesis of mycosis fungoides.

Authors:  G Rowden; M G Lewis
Journal:  Br J Dermatol       Date:  1976-12       Impact factor: 9.302

3.  Rabbit antisera to human B cell alloantigens: effects on the mixed lymphocyte response.

Authors:  S S Geier; P Cresswell
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

4.  The use of freshly explanted mouse epidermal cells for the in vitro induction and detection of cell-mediated cytotoxicity.

Authors:  D Steinmuller; J R Wunderlich
Journal:  Cell Immunol       Date:  1976-06-01       Impact factor: 4.868

5.  An ultrastructural staining method for enhancing the size and electron opacity of ferritin in thin sections.

Authors:  S K Ainsworth; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1972-03       Impact factor: 2.479

6.  The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

Authors:  D C Shreffler; C S David
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

7.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

8.  Cellular distrubtion, purification, and molecular nature of human Ia antigens.

Authors:  D Snary; C J Barnstable; W F Bodmer; P N Goodfellow; M J Crumpton
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  Graft-versus-host reactions across different regions of the H-2 complex of the mouse.

Authors:  J Klein; J M Park
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

10.  Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci.

Authors:  J Klein; R Geib; C Chiang; V Hauptfeld
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  3 in total

1.  Biochemical documentation of allelic variation of the I-E antigens of the d, k, p, r, and u haplotypes.

Authors:  J M Kupinski; P A Gamble; C S David; J H Freed
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

2.  Peptide map comparisons of epidermal and spleen H-2 molecules.

Authors:  J G Frelinger; J A Frelinger; L Hood
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

3.  Analysis of neonatally induced tolerance of H-2 alloantigens. I. Adoptive transfer indicates that tolerance of class I and class II antigens is maintained by distinct mechanisms.

Authors:  J W Streilein; R S Gruchalla
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.